Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Gentile

Podiatrist, Foot & Ankle Surgery Huntington, WV Doctor of Podiatric Medicine

NPI 1124087846 CMS profile 96593

1600 Medical Center Dr Ste G500, Huntington, WV 25701

Open in the dashboard

General payments

$102,507

133 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$420,502

7 holdings reported · through program year 2025

Research they led as principal investigator

$6,850 paid to institutions, not to them · program years 2020–2023

Through program year 2025, Michael Gentile of Huntington, WV is reported in the CMS Open Payments database as having received $102,507 across 133 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $6,850 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $420,502 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,849 20
2024 General $5,275 13
2023 General $44,551 31
2022 General $21,370 25
2021 General $10,794 12
2020 General $2,417 4
2019 General $12,250 28
2025 Ownership $61,667 1
2024 Ownership $61,992 1
2023 Ownership $86,054 1
2022 Ownership $86,901 1
2021 Ownership $68,532 1
2020 Ownership $29,485 1
2019 Ownership $25,871 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Gentile
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Michael Gentile were reported at $5,849. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Michael Gentile Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $12,250 $389 $118–$1,406 $163
2020 $2,417 $191 $62–$691 $114
2021 $10,794 $329 $104–$1,341 $132
2022 $21,370 $419 $125–$1,611 $149
2023 $44,551 $377 $128–$1,164 $160
2024 $5,275 $394 $134–$1,168 $164
2025 $5,849 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Paragon 28, Inc. $41,728 22 payments
  2. Tyber Medical, LLC $23,665 10 payments
  3. Flower Orthopedics Coporation $12,451 22 payments
  4. Synthes GmbH $9,004 16 payments
  5. Avitus Orthopaedics, Inc. $2,625 2 payments
  6. Mid-Atlantic Surgical Systems, LLC $2,551 4 payments
  7. Medical Device Business Services, Inc. $1,975 1 payment
  8. International Life Sciences $1,900 1 payment
  9. Treace Medical Concepts, Inc. $1,808 17 payments
  10. Vilex in Tennessee, Inc. $1,758 5 payments
  11. Other $3,041 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $59,632 14 payments
  2. Travel and Lodging $15,220 28 payments
  3. Royalty or License $11,942 20 payments
  4. Food and Beverage $5,778 62 payments
  5. Current or prospective ownership or investment interest $3,785 3 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $3,750 4 payments
  7. Education $2,400 2 payments
Products named General payments · program years 2019–2025
  1. PORTFOLIO $33,111 11 payments
  2. Tyber Medical Anatomical Plating System $15,378 4 payments
  3. MTP Plate, 5 Holes, Left $6,547 15 payments
  4. MTP Plate, 5 Holes, Right $6,547 15 payments
  5. Elongated L-Plate, 4 Holes, (R), $6,135 14 payments
  6. 1.7mm Elongated L-Plate, 5 Holes, (R), $5,565 13 payments
  7. Akin Plate, 2 Holes, use with 1.5mm/2.0mm/2.4mm screws $5,565 13 payments
  8. Product Portfolio $4,887 3 payments
  9. Tyber Medical Trauma Screw System $3,510 2 payments
  10. Cannulated Compression Headless Screw $3,510 2 payments
  11. Other $17,131 66 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

30

Median for Podiatry: 160

Drug cost

$250

Median for Podiatry: $2,368

Branded share of claims

53.3%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 16 $146
Oxycodone Hcl Generic 14 $104

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $22
$22 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record